Advancing the Standard of Clinical Immunology Education
Modern clinicians are currently facing a fragmented landscape of unorganized data that fails to bridge the gap between complex science and clinical mastery. ImmunoStudio is dedicated to distilling this vast body of knowledge into a structured, evidence-based ecosystem—empowering the next generation to pass their boards and lead their field with absolute confidence.
Evidence-Based Clinical Logic for Board Mastery
HAE Diagnostics
Complement Signaling
Did you know? Normal C4 levels are observed in HAE with normal C1-INH (Type III) during acute attacks. While Type I and II typically show low C4, all forms can present with normal levels outside of acute episodes.
Source:ImmunoBank Q1
Venom Sensitivity
Recurrence Risk
A large local reaction to an insect sting carries only a 5-10% likelihood of recurrence on subsequent stings. While common with repeated exposure, these reactions are rarely associated with systemic anaphylaxis.
Source:ImmunoBank Q5
Environmental Allergens
Recurrence Risk
“Hypoallergenic” cat breeds are a clinical myth. The major allergen, Fel d 1, is produced in salivary and sebaceous glands—not just fur. Hairless breeds still trigger significant allergic responses in sensitized patients.
Source:ImmunoBank Q5
Get your free 10-Question High-Yield Sampler and join a community of clinicians dedicated to clinical excellence.
Announcing
immunobank!
The premier QBank for the 2026 ABAI Boards. 400+ peer-reviewed questions with high-yield rationales.